India to Canada: Protein Export Trade Route
India has recorded 38 verified shipments of Protein exported to Canada, representing a combined trade value of $5.2M USD. This corridor is served by 3 active Indian exporters, with an average shipment value of $135.7K USD. The leading Indian exporter is PANACEA BIOTEC PHARMA LIMITED, which accounts for 100% of total export value with 36 shipments worth $5.2M USD. On the buying side, APOTEX CORP is the largest importer in Canada with $2.4M USD in purchases. The top 3 suppliers — PANACEA BIOTEC PHARMA LIMITED, JUBILANT BIOSYS LIMITED , SYNGENE INTERNATIONAL LIMITED — together control 100% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.

Route Intelligence Overview
The India to Canada Protein corridor is one of India's established pharmaceutical export routes, with 38 shipments documented worth a combined $5.2M USD. The route is dominated by PANACEA BIOTEC PHARMA LIMITED, which alone accounts for roughly 100% of all export value, reflecting the consolidated nature of India's protein manufacturing sector.
Across 3 active suppliers, the average shipment value stands at $135.7K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (66%) and air (16%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during April–June, with an average transit time of 24 days port-to-port. The route has recorded an annual growth rate of 14.1%, placing it at rank #11 among India's top protein export destinations globally.
On the import side, key buyers of Indian protein in Canada include APOTEX CORP, APOTEX INC., APOTEX INC and 3 others. APOTEX CORP is the single largest importer with 14 shipments valued at $2.4M USD.
Route Characteristics
- Average transit24 days
- Peak seasonQ2
- Primary modeMulti-modal
- Top portDELHI AIR
Market Position
- Global rank#11
- Annual growth+14.1%
- Demand growth+12.4%
- Regulatory ease66/100
Top 10 Indian Protein Exporters to Canada
Showing top 10 of 3 Indian suppliers exporting Protein to Canada, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | PANACEA BIOTEC PHARMA LIMITED Avg $143.2K per shipment | 36 | $5.2M | 100.0% |
| 2 | JUBILANT BIOSYS LIMITED Avg $12 per shipment | 1 | $12 | 0.0% |
| 3 | SYNGENE INTERNATIONAL LIMITED Avg $6 per shipment | 1 | $6 | 0.0% |
This table shows the top 10 of 3 Indian companies exporting protein to Canada, ranked by total trade value. The listed exporters are: PANACEA BIOTEC PHARMA LIMITED, JUBILANT BIOSYS LIMITED , SYNGENE INTERNATIONAL LIMITED. PANACEA BIOTEC PHARMA LIMITED is the dominant supplier with 36 shipments worth $5.2M USD, giving it a 100% market share.
Top 10 Protein Importers in Canada
Showing top 10 of 6 known buyers in Canada receiving Protein shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian protein in Canada include APOTEX CORP, APOTEX INC., APOTEX INC, APOTEX INC - SIGNET, M/S RAPID NOVOR INC , among 6 total buyers. The largest importer is APOTEX CORP, accounting for $2.4M USD across 14 shipments — representing 47% of all protein imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | APOTEX CORP | 14 | $2.4M | 46.5% |
| 2 | APOTEX INC. | 12 | $1.5M | 28.8% |
| 3 | APOTEX INC | 9 | $1.2M | 22.5% |
| 4 | APOTEX INC - SIGNET | 1 | $117.4K | 2.3% |
| 5 | M/S RAPID NOVOR INC | 1 | $12 | 0.0% |
| 6 | ImmunoPrecise Antibodies Canada Ltd | 1 | $6 | 0.0% |
Top 10 Protein Formulations Imported by Canada
Showing top 10 of 36 product formulations shipped on the India to Canada Protein route, ranked by trade value
Canada imports a wide range of protein formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — PACLITAXEL PROTEIN-BOUND P ARTICLE / ODS / PRODUCT / ITEM FORINJECTABLE SUSPENSION 100 MG B/N 907023010 907023011 M/D.09/2023 E/D.08/2025 B — accounts for $771.3K USD across 2 shipments. There are 36 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | PACLITAXEL PROTEIN-BOUND P ARTICLE / ODS / PRODUCT / ITEM FORINJECTABLE SUSPENSION 100 MG B/N 907023010 907023011 M/D.09/2023 E/D.08/2025 B | 2 | $771.3K | 15.0% |
| 2 | PACLITAXEL ( PROTEIN-BOUND PARTICLES FORINJECTABLE SUSPENSION 100 MG) B/N.907024024 M/D.01/2025 E/D.12/2026. | 2 | $279.3K | 5.4% |
| 3 | PACLITAXEL PROTEIN BOUND P ARTICLE / ODS / PRODUCT / ITEM FOR | 1 | $267.5K | 5.2% |
| 4 | PACLITAXEL (PROTEIN BOUND PARTICLES FOR | 1 | $190.2K | 3.7% |
| 5 | PACLITAXEL (PROTEIN-BOUND PARTICLES FORINJECTABLE SUSPENSION 100 MG) B/N.907023022 M/D.03/2024 E/D.02/2026. | 1 | $141.8K | 2.7% |
| 6 | PACLITAXEL ( PROTEIN-BOUND PARTICLES FORINJECTABLE SUSPENSION 100MG) B/N.907024021 M/D.01/2025 E/D.12/2026. | 1 | $139.2K | 2.7% |
| 7 | PACLITAXEL (PROTEIN-BOUND PARTICLES FORINJECTABLE SUSPENSION 100 MG) B/N.907024010 M/D.06/2024 E/D.05/2026 | 1 | $138.8K | 2.7% |
| 8 | PACLITAXEL (PROTEIN-BOUND PARTICLES FORINJECTABLE SUSPENSION 100 MG) B/N.907024008 M/D.06/2024 E/D.05/2026 | 1 | $138.3K | 2.7% |
| 9 | PACLITAXEL ( PROTEIN-BOUND PARTICLES FORINJECTABLE SUSPENSION 100 MG) B/N.907024025 M/D.01/2025 E/D.12/2026. | 1 | $138.2K | 2.7% |
| 10 | PACLITAXEL (PROTEIN-BOUND PARTICLES FORINJECTABLE SUSPENSION 100 MG) B/N.907024009 M/D.06/2024 E/D.05/2026 | 1 | $137.8K | 2.7% |
Showing top 10 of 36 Protein formulations imported by Canada on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Balanced freight mix — 66% sea for bulk, 16% air for urgent orders.
Top Ports of Origin
DELHI AIR handles the highest volume with 23 shipments. Transit time averages 24 days by sea.
Market Dynamics
India's protein exports to Canada are driven primarily by a handful of large-scale manufacturers. PANACEA BIOTEC PHARMA LIMITED with 36 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 3 active exporters signals a competitive but concentrated market — buyers in Canada benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — PANACEA BIOTEC PHARMA LIMITED, JUBILANT BIOSYS LIMITED , SYNGENE INTERNATIONAL LIMITED — together account for 100% of total trade value on this route. The average shipment value of $135.7K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
Beyond the primary product category, shipments on this route include closely related formulations such as paclitaxel ( protein-bound particles forinjectable suspension 100 mg) b/n.907024024 m/d.01/2025 e/d.12/2026. and paclitaxel protein bound p article / ods / product / item for, suggesting that buyers in Canada tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, APOTEX CORP is the largest importer with 14 shipments worth $2.4M USD — representing 47% of all protein imports from India on this route. A total of 6 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $5.2M
- Avg. Shipment
- $135.7K
- Suppliers
- 3
- Buyers
- 6
- Transit (Sea)
- ~24 days
- Annual Growth
- +14.1%
Reverse Direction
Canada → India — Protein (Import)Other Protein Routes
Unlock the Full India to Canada Protein Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 38 shipments on this route.
Frequently Asked Questions — India to Canada Protein Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Protein to Canada?
The leading Indian exporters of Protein to Canada are PANACEA BIOTEC PHARMA LIMITED, JUBILANT BIOSYS LIMITED , SYNGENE INTERNATIONAL LIMITED. PANACEA BIOTEC PHARMA LIMITED holds the largest market share at approximately 100% of total trade value on this route.
Q What is the total value of Protein exports from India to Canada?
India exports Protein to Canada worth approximately $5.2M USD across 38 recorded shipments. The average value per shipment is $135.7K USD.
Q Which ports does India use to ship Protein to Canada?
The most active port of origin is DELHI AIR with 23 shipments. Indian exporters primarily use a mix of sea and air freight for this route, with 66% of shipments going by sea and 16% by air.
Q How long does shipping take from India to Canada for Protein?
The average transit time for Protein shipments from India to Canada is approximately 24 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during April–June.
Q Is the India to Canada Protein trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 14.1% with demand growth tracking at 12.4%. The route is ranked #11 among India's top Protein export destinations globally.
Q How many suppliers are active on the India to Canada Protein route?
There are currently 3 active Indian suppliers exporting Protein to Canada. The market is moderately concentrated with PANACEA BIOTEC PHARMA LIMITED accounting for 100% of total shipment value.
Q Who are the main importers of Protein from India in Canada?
The leading importers of Indian Protein in Canada include APOTEX CORP, APOTEX INC., APOTEX INC, APOTEX INC - SIGNET, M/S RAPID NOVOR INC . APOTEX CORP is the largest buyer with 14 shipments worth $2.4M USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Canada export trade corridor identified from Indian Customs (DGFT) records for Protein.
- 2.Supplier/Buyer Matching: 3 Indian exporters and 6 importers in Canada matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 38 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
38 Verified Shipments
3 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists